Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Sorrentino
Dario
D
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D003424:Crohn Disease / Q000150:complications*; D005765:Gastrointestinal Agents / Q000009:adverse effects; D006801:Humans; D000069285:Infliximab; D007415:Intestinal Obstruction / Q000209:etiology*; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab